No Data
No Data
Plus Therapeutics to Present at the Gordon Research Conference Radionuclide Theranostics for the Management of Cancer
AUSTIN, Texas, July 02, 2024 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company"), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform
Plus Therapeutics to Receive $3.3 Million Advance Payment From CPRIT For Radiotherapeutic Development Program
Plus Therapeutics (PSTV) said Friday it received notice of a $3.3 million advance payment from the Cancer Prevention & Research Institute of Texas, or CPRIT, as part of a $17.6 million grant awarded i
Express News | PLUS THERAPEUTICS Says Greg Fuller Joins Company As Vice President Of Medical Affairs And Medical Director; Reports $3.3M Advance Payment From CPRIT
Express News | Plus Therapeutics Expands Management Team and Reports $3.3M Advance Payment From Cprit
Express News | Aigh Capital Management, LLC Reports Passive Stake of 9.9% in Plus Therapeutics Inc as of May 9, 2024- SEC Filing
Express News | Plus Therapeutics Inc - on May 31, Drew $3.3 Mln on Its Existing Margin Loan Facility With Pershing LLC
No Data
RideTheTide : Good news, why stock is down instead?